BOSTON–(BUSINESS WIRE)–AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, announced today it has entered into a Collaborative Research Agreement with the University of Missouri-Columbia to work with Dr. Carolyn Anderson, Simón-Ellebracht Professor in Medicinal Chemistry and Professor of Radiology, and her team to jointly pursue specific research projects to advance the use of de novo designed miniproteins for targe